Skip to content
10-Q

Quarterly Report

MBX Biosciences, Inc. MBX

0001193125-25-268148

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 3, 2025 44.9M sh
Shares Diluted Q3 2025 · Sep 30, 2025 34.2M sh
Shares Diluted Q3 2025 · Sep 30, 2025 33.69M sh
Shares Diluted Q3 2025 · Sep 30, 2024 6.52M sh
Shares Diluted Q3 2025 · Sep 30, 2024 3M sh
Capex Q3 2025 · Sep 30, 2025 $1.14M
Capex Q3 2025 · Sep 30, 2024 $782K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$61.65M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$38.64M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $223.13M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $49.35M
Stockholders Equity Q3 2025 · Sep 30, 2025 $387.54M
Stockholders Equity Q3 2025 · Jun 30, 2025 $219.24M
Stockholders Equity Q3 2025 · Mar 31, 2025 $235.42M
Stockholders Equity Q3 2025 · Dec 31, 2024 $257.44M
Stockholders Equity Q3 2025 · Sep 30, 2024 $271.37M
Stockholders Equity Q3 2025 · Jun 30, 2024 −$97.89M
Stockholders Equity Q3 2025 · Mar 31, 2024 −$83.05M
Stockholders Equity Q3 2025 · Dec 31, 2023 −$72.47M
Current Liabilities Q3 2025 · Sep 30, 2025 $12.06M
Current Liabilities Q3 2025 · Dec 31, 2024 $11.05M
Total Liabilities Q3 2025 · Sep 30, 2025 $12.54M
Total Liabilities Q3 2025 · Dec 31, 2024 $11.09M
Current Assets Q3 2025 · Sep 30, 2025 $397.5M
Current Assets Q3 2025 · Dec 31, 2024 $267.29M
Total Assets Q3 2025 · Sep 30, 2025 $400.08M
Total Assets Q3 2025 · Dec 31, 2024 $268.54M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.63
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.93
Eps Diluted Q3 2025 · Sep 30, 2024 −$2.78
Eps Diluted Q3 2025 · Sep 30, 2024 −$15.42
Eps Basic Q3 2025 · Sep 30, 2025 −$0.63
Eps Basic Q3 2025 · Sep 30, 2025 −$1.93
Eps Basic Q3 2025 · Sep 30, 2024 −$2.78
Eps Basic Q3 2025 · Sep 30, 2024 −$15.42
Sga Expense Q3 2025 · Sep 30, 2025 $4.66M
Sga Expense Q3 2025 · Sep 30, 2025 $12.86M
Sga Expense Q3 2025 · Sep 30, 2024 $2.87M
Sga Expense Q3 2025 · Sep 30, 2024 $7.39M
Rd Expense Q3 2025 · Sep 30, 2025 $19.27M
Rd Expense Q3 2025 · Sep 30, 2025 $59.4M
Rd Expense Q3 2025 · Sep 30, 2024 $16.75M
Rd Expense Q3 2025 · Sep 30, 2024 $42.19M
Net Income Q3 2025 · Sep 30, 2025 −$21.62M
Net Income Q3 2025 · Sep 30, 2025 −$64.91M
Net Income Q3 2025 · Jun 30, 2025 −$19.41M
Net Income Q3 2025 · Mar 31, 2025 −$23.88M
Net Income Q3 2025 · Dec 31, 2024 −$61.9M
Net Income Q3 2025 · Sep 30, 2024 −$18.14M
Net Income Q3 2025 · Sep 30, 2024 −$46.34M
Net Income Q3 2025 · Jun 30, 2024 −$15.86M
Net Income Q3 2025 · Mar 31, 2024 −$12.34M
Operating Income Q3 2025 · Sep 30, 2025 −$23.93M
Operating Income Q3 2025 · Sep 30, 2025 −$72.26M
Operating Income Q3 2025 · Sep 30, 2024 −$19.61M
Operating Income Q3 2025 · Sep 30, 2024 −$49.58M